Close
Close
Finance News

NewLink Genetics to Participate in November Investor Conferences

4.5
4.5 from 2 votes
Tuesday, November 14, 2017

AMES, Iowa - NewLink Genetics Corporation (NASDAQ:NLNK) will participate in the following investor conferences this week:

Stifel 2017 Healthcare Conference on Tuesday, November 14th, at 5:00pm ET in New York City
Jefferies 2017 London Healthcare Conference on Thursday, November 16th, at 17:20 GMT (12:20pm ET)

A live webcast of both conference presentations will be on the Company's website at www.newlinkgenetics.com in the "Investors & Media" section under "Events and Presentations."

About NewLink Genetics Corporation

NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' IDO pathway inhibitors are designed to harness multiple components of the immune system to combat cancer. Indoximod is being evaluated in combination with treatment regimens including anti-PD-1/PD-L1 agents, cancer vaccines, and chemotherapy across multiple indications such as melanoma, pancreatic cancer and other malignancies. For more information, visit www.newlinkgenetics.com, and follow us on Twitter @NLNKGenetics.

Source: NewLink Genetics Corporation
4.5
4.5 from 2 votes
Free Newsletter
Videos
by Scott Harwood
17 views
by Abidemi Uruejoma
17 views
by Scott Harwood
17 views